Oculid uses precise gaze tracking algorithms on mobile phone cameras to help marketing and UX teams better understand their users’ attention and behaviour towards their products and marketing campaigns prior to releasing them.

“The future of user testing is here. Before Oculid, eye tracking user testing was costly and artificially produced in labs, therefore not widely used or even known. We are changing that by providing highly accurate tests that can be done using smartphones in a remote setting at a fraction of the in-lab costs.

"This means anyone anywhere can find out if their webpage is intuitive or their marketing campaign is effective, before launching it, which can result in significant cost savings for those companies,” said Dr. Antje Venjakob, Oculid’s CEO. “On top of that, considering today’s circumstances caused by the pandemic, we allow companies to continue gaining valuable insights into their users’ behaviours regardless of where they are located.” 

The new funds will be used to expand Oculid’s presence in the European market and to strengthen their testing platform features including a launch of an iOS testing capability. This will include expanding their team of engineers and marketers.

"We were impressed by the innovative business focus and the TU Berlin spin-off team led by a female founder Dr. Antje Venjakob," said Sabine Wolff, Investment Manager at IBB Ventures.

"Oculid is a great team with a highly innovative product providing significant customer benefit and an outstanding opportunity. I am very happy to continue to join their journey," said business angel Alfred Moeckel.